What are the top competitors of UPR.IR in Healthcare sector?

The top competitors of UPR.IR in the Healthcare sector are: Bastide Le Confort Médical SA (BLC.PA), Metrics in Balance N.V. (MLMIB.PA).

Which has better valuations & earnings, UPR.IR or its competitors?

UPR.IR has a market cap of 943.6M and a Dividend Yield of 0.53% compared to its competitors.

Which stock is more profitable: UPR.IR or its competitors?

UPR.IR has an EPS of €0.23, while BLC.PA has an EPS of €1.16. So, UPR.IR is more profitable compared to BLC.PA.

What is UPR.IR stock volatility and risk in terms of investment?

UPR.IR has daily volatility of 2.88% as compared to its competitor BLC.PA which is 3.1%. UPR.IR is less volatile as compared to competitors and has low risk.

Is UPR.IR stock profitable?

UPR.IR has a Return on Equity (ROE) of 0.08%. So, UPR.IR is more profitable.

What is UPR.IR stock’s 52 weeks high and low?

UPR.IR stock has a 52-week high of (€3.7) and a low of (€1.904).

What was the average volume of UPR.IR stock?

The average volume of UPR.IR is (772.1K) in terms of investment.

Uniphar plc (UPR.IR) Competitors

Uniphar plc UPR.IR Peers

See (UPR.IR) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Distribution Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
UPR.IR	€3.64	-0.55%	943.6M	15.80	€0.23	+0.53%
BLC.PA	€27.05	-2.35%	197.7M	23.32	€1.16	N/A
MLMIB.PA	€0.03	N/A	790.3K	-3.30	-€0.01	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

UPR.IR vs BLC.PA Comparison

UPR.IR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UPR.IR stands at 943.6M. In comparison, BLC.PA has a market cap of 197.7M. Regarding current trading prices, UPR.IR is priced at €3.64, while BLC.PA trades at €27.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UPR.IR currently has a P/E ratio of 15.80, whereas BLC.PA's P/E ratio is 23.32. In terms of profitability, UPR.IR's ROE is +0.08%, compared to BLC.PA's ROE of +0.02%. Regarding short-term risk, UPR.IR is less volatile compared to BLC.PA. This indicates potentially lower risk in terms of short-term price fluctuations for UPR.IR.

Uniphar plc